Promethazine is a potent antihistamine and sedative that can be used to treat various medical conditions, such as allergies, motion sickness, and insomnia. As with any medication, determining the right Promethazine dosage is crucial for safe and effective treatment. In this blog post, we'll explore everything medical professionals need to know about Promethazine dosage so they can prescribe it confidently and help their patients find relief from symptoms while avoiding any adverse effects.
Promethazine is an antihistamine and works by blocking the natural chemical histamine that your body makes during an allergic reaction. It also works as an antiemetic to help control nausea and vomiting. Promethazine comes in tablet, syrup, and suppository form and is usually taken orally. The typical adult dose for promethazine is 25 mg twice daily.
Promethazine is an antihistamine and works by blocking histamine receptors. It is commonly used to treat allergies, but can also be used to treat nausea, vomiting, and motion sickness. Promethazine can also be used as a sedative for both adults and children.
The standard recommended Promethazine dosage for different conditions is as follows: For the temporary relief of runny nose and sneezing due to the common cold, hay fever, or upper respiratory allergies: Adults and children 12 years of age and older—25 mg (Promethazine HCl) tablet, orally every 4 to 6 hours as needed. Children 6 to 11 years of age—12.5 mg (Promethazine HCl) tablet, orally every 4 to 6 hours as needed. For preoperative sedation in children: Children 2 years of age and older—Dose is based on body weight and must be determined. The usual dose is 0.5 mg per pound (0.23 mg per kg) of body weight injected into a vein or muscle no more often than once every four hours, not to exceed 40 mg in 24 hours for any child. For motion sickness: Adults and children 12 years of age and older—25 mg taken at bedtime or 6.25 to 12.5 mg taken three times a day as needed. Children 6 to 11 years of age—12.5 mg taken at bedtime or 3.125 to 6.25 mg taken three times a day as needed. For nausea and vomiting associated with cancer chemotherapy: Adults and children 16 years of age and older—25 mg injected slowly into a vein over 10 minutes two or three times daily, starting within 30 minutes before.
The most common side effects of Promethazine are: Drowsiness, Dizziness, Nausea and vomiting, Constipation, Blurred vision, Dry mouth. Less common side effects include:
Allergic reactions (rash, hives, difficulty breathing), Agitation or nervousness, Anxiety, Seizures, Fast or irregular heartbeat, High blood pressure, Fainting. Rare side effects include: Toxicology studies in animals have revealed evidence of embryotoxicity, fetotoxicity, and teratogenicity. These effects were noted at doses of 10-15 times the maximum recommended human dose (MRHD) of 25 mg/day. In rats and rabbits, respectively, these doses produced maternal toxicity (reduced body weight gain), embryo-fetal mortality, and growth retardation. There was no evidence of malformations. No adequate studies have been conducted in animals to determine whether Promethazine has a potential for carcinogenesis or mutagenesis.
Promethazine should not be taken if the patient is allergic to it, has certain medical conditions, or is taking certain other medications. Patients with a known allergy to promethazine should not take the medication. Promethazine should also be avoided in patients with liver disease, as it can increase the risk of liver toxicity. Additionally, promethazine should not be taken by pregnant women or nursing mothers, as it may cause harm to the developing fetus or infant. Finally, patients taking MAO inhibitors or other antipsychotic medications should not take promethazine, as it can interact with these drugs and cause serious side effects.
Promethazine is a medication with many potential uses and benefits but requires careful dosing to ensure safety. Understanding how to properly prescribe the right amount of promethazine for each patient is important to maximize treatment efficacy while avoiding any adverse effects. By following the general recommendations outlined by medical professionals, you can develop an effective plan for safely administering this drug to patients.
1.
PET-CT finds further-reaching metastases in patients with locally advanced breast cancer.
2.
Reasons Behind Refusing Stem Cell Transplantation in Certain Myeloma Patients.
3.
Hospitalization and mortality rates are associated with exposure to the omicron variant of COVID-19 in patients with solid cancer.
4.
AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer
5.
In heavily pretreated DLBCL, Triplet Scores a Survival Victory.
1.
The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape
2.
Is AI The New Radiologist For Breast MRI?
3.
Uncovering New Hope for Follicular Lymphoma Patients
4.
The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late
5.
Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
2.
Efficient Management of First line ALK-rearranged NSCLC - Part V
3.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation